Table Of Contents:
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Component
2.3.2 Market Size By Application
2.3.3 Market Size By Medical Condition
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO's Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter's) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1. Algorithm Developers & Data Providers
3.4.2. Imaging & Device Hardware Manufacturers
3.4.3. Hospitals, Health Systems & Diagnostic Centers
3.4.4. Payers, Regulators & End Patients
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Clinical Validation & Accuracy Metrics
4.1.1 Diagnostic Sensitivity & Specificity Benchmarks
4.1.2 Peer-Reviewed Study Volume & Outcomes
4.1.3 Clinical Trial Registration Trends
4.1.4 Real-World Performance Monitoring
4.2 Regulatory & Clearance Statistics
4.2.1 FDA 510(k) & De Novo Clearance Counts
4.2.2 CE Mark & EU AI Act Compliance Trends
4.2.3 Asia Pacific National Approval Activity
4.2.4 Post-Market Surveillance Requirements
4.3 Reimbursement & Monetization Efficiency
4.3.1 AI-Specific CPT & Billing Code Adoption
4.3.2 Payer Coverage Policy Expansion
4.3.3 Hospital Capital versus Subscription Spending
4.3.4 Customer Acquisition Cost Trends
4.4 Disease Burden & Workforce Context
4.4.1 Cardiovascular Disease Prevalence & Mortality
4.4.2 Cardiologist & Sonographer Workforce Shortages
4.4.3 Wearable & Remote Monitoring Data Volume
4.4.4 Aging Population Impact on Caseload
4.5 Innovation, Technology & Development Outcomes
4.5.1 Multimodal & Generative Model Development
4.5.2 Cloud & Electronic Health Record Integration
4.5.3 Point-of-Care & Wearable Device Pairing
4.5.4 Funding, Partnerships & Acquisition Activity
5. AI in Cardiology Market Segmental Analysis, By Component
5.1 Introduction
5.2 Software
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Hardware
5.4 Services
6. AI in Cardiology Market Segmental Analysis, By Application
6.1 Introduction
6.2 Diagnosis
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Prediction
6.4 Drug Discovery
6.5 Others
7. AI in Cardiology Market Segmental Analysis, By Medical Condition
7.1 Introduction
7.2 Ischemic Heart Disease
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Cardiac Arrhythmias
7.4 Heart Failure
7.5 Others
9. AI in Cardiology Market Segmental Analysis, By Region
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 AI in Cardiology Market Size & Forecast, By Component, 2022–2035
9.2.3 AI in Cardiology Market Size & Forecast, By Application, 2022–2035
9.2.4 AI in Cardiology Market Size & Forecast, By Medical Condition, 2022–2035
9.2.6 AI in Cardiology Market Size & Forecast, By Country, 2022–2035
9.2.6.1 US
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 AI in Cardiology Market Size & Forecast, By Component, 2022–2035
9.3.3 AI in Cardiology Market Size & Forecast, By Application, 2022–2035
9.3.4 AI in Cardiology Market Size & Forecast, By Medical Condition, 2022–2035
9.3.6 AI in Cardiology Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 France
9.3.6.3 UK
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Poland
9.3.6.7 Russia
9.3.6.8 Rest of Europe
9.4 Asia Pacific
9.4.1 Key Trends
9.4.2 AI in Cardiology Market Size & Forecast, By Component, 2022–2035
9.4.3 AI in Cardiology Market Size & Forecast, By Application, 2022–2035
9.4.4 AI in Cardiology Market Size & Forecast, By Medical Condition, 2022–2035
9.4.6 AI in Cardiology Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 AI in Cardiology Market Size & Forecast, By Component, 2022–2035
9.5.3 AI in Cardiology Market Size & Forecast, By Application, 2022–2035
9.5.4 AI in Cardiology Market Size & Forecast, By Medical Condition, 2022–2035
9.5.6 AI in Cardiology Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 AI in Cardiology Market Size & Forecast, By Component, 2022–2035
9.6.3 AI in Cardiology Market Size & Forecast, By Application, 2022–2035
9.6.4 AI in Cardiology Market Size & Forecast, By Medical Condition, 2022–2035
9.6.6 AI in Cardiology Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 South Africa
9.6.6.5 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Year-Wise Strategies & Development, 2022–2026
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 GE HealthCare Technologies Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 Geographical Presence
10.6.1.5 SWOT Analysis
10.6.2 Koninklijke Philips N.V.
10.6.3 Siemens Healthineers AG
10.6.4 Canon Medical Systems Corporation
10.6.5 Medtronic plc
10.6.6 Viz.ai, Inc.
10.6.7 HeartFlow, Inc.
10.6.8 Cleerly, Inc.
10.6.9 Ultromics Limited
10.6.10 Eko Health, Inc.
10.6.11 AliveCor, Inc.
10.6.12 Anumana, Inc.
10.6.13 iRhythm Technologies, Inc.
10.6.14 Boston Scientific Corporation
10.6.15 Idoven S.L.
10.6.16 Implicity SAS
10.6.17 Circle Cardiovascular Imaging Inc.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
The market includes GE HealthCare, Philips, Siemens Healthineers, Canon Medical Systems, Medtronic, Viz.ai, HeartFlow, Cleerly, Ultromics, Eko Health, AliveCor, Anumana, iRhythm Technologies, Boston Scientific, Idoven, Implicity, and Circle Cardiovascular Imaging, among others.
The main opportunities lie in new reimbursement codes for AI-assisted cardiac services and expansion into underserved markets across Asia Pacific, the Middle East, Africa and Latin America, where specialist cardiologists remain scarce relative to patient populations.
The key growth factor is the combination of a rising cardiovascular disease burden and a persistent shortage of cardiologists and sonographers, which pushes hospitals toward AI tools that triage, diagnose and predict cardiac disease at scale.
By component, the Hardware segment dominated the market with approximately 37.40% share in 2025, as AI capability remains most often bundled into imaging equipment rather than sold as standalone software.
North America dominated the market with approximately 44.85% share in 2025, supported by dense academic medical centers and early regulatory clearance activity. Asia Pacific is the fastest-growing region with a projected CAGR of 33.80% from 2026 to 2035.
